Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.
Onkologie
; 35(3): 118-20, 2012.
Article
in En
| MEDLINE
| ID: mdl-22414976
ABSTRACT
We report the case of a 62-year-old woman with a metastatic gastric cancer complicated by diffuse bone marrow carcinomatosis, disseminated intravascular coagulation (DIC) and microangiopathic hemolytic anemia (MHA) treated by modified FOLFOX-6 as front-line chemotherapy regimen. This chemotherapy showed clinical, morphological and biological efficiency and safety in this rare and severe hematological complication at initial diagnosis. Furthermore, this is the first case of diffuse bone carcinomatosis from a gastric cancer to be monitored by positron emission tomography integrated computed tomography (PET-CT) scan using 18-fluorodeoxyglucose (18-FDG).
Full text:
1
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Carcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Carcinoma, Signet Ring Cell
/
Bone Marrow Neoplasms
/
Disseminated Intravascular Coagulation
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Year:
2012
Type:
Article